Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Trading Up 0.2% – What’s Next?

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)’s stock price traded up 0.2% during trading on Friday . The company traded as high as $10.69 and last traded at $10.7140. Approximately 191 shares changed hands during mid-day trading, a decline of 99% from the average daily volume of 28,144 shares. The stock had previously closed at $10.69.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of Oaktree Acquisition Corp. III Life Sciences in a report on Tuesday, June 30th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Oaktree Acquisition Corp. III Life Sciences presently has an average rating of “Sell”.

Oaktree Acquisition Corp. III Life Sciences Stock Up 0.2%

The company’s fifty day moving average is $10.69 and its 200 day moving average is $10.66.

Hedge Funds Weigh In On Oaktree Acquisition Corp. III Life Sciences

Several hedge funds have recently made changes to their positions in the stock. Clear Street Group Inc. bought a new stake in shares of Oaktree Acquisition Corp. III Life Sciences during the 3rd quarter valued at $231,000. Rangeley Capital LLC grew its holdings in Oaktree Acquisition Corp. III Life Sciences by 52.8% during the 1st quarter. Rangeley Capital LLC now owns 61,188 shares of the company’s stock valued at $647,000 after buying an additional 21,156 shares in the last quarter. Radcliffe Capital Management L.P. bought a new stake in shares of Oaktree Acquisition Corp. III Life Sciences during the second quarter valued at about $856,000. UBS Group AG increased its position in shares of Oaktree Acquisition Corp. III Life Sciences by 987,110.0% during the third quarter. UBS Group AG now owns 98,721 shares of the company’s stock valued at $1,038,000 after buying an additional 98,711 shares during the period. Finally, DLD Asset Management LP increased its position in shares of Oaktree Acquisition Corp. III Life Sciences by 0.9% during the first quarter. DLD Asset Management LP now owns 136,735 shares of the company’s stock valued at $1,447,000 after buying an additional 1,200 shares during the period.

Oaktree Acquisition Corp. III Life Sciences Company Profile

Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC) is a special purpose acquisition company (“SPAC”) formed to pursue merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combinations with one or more businesses in the life sciences sector. Incorporated as a Cayman Islands exempted company, OACC is sponsored by Oaktree Capital Management, a global alternative investment firm with a longstanding track record in credit strategies and private equity.